Holocene Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
+403,172
| New | +$5.64M | 0.01% | 351 |
|
|
2025
Q1 | – | Sell |
-199,072
| Closed | -$4.06M | – | 769 |
|
|
2024
Q4 | $4.06M | Buy |
199,072
+101,625
| +104% | +$2.07M | 0.01% | 423 |
|
|
2024
Q3 | $2.84M | Buy |
97,447
+38,405
| +65% | +$1.12M | 0.01% | 485 |
|
|
2024
Q2 | $1.37M | Sell |
59,042
-801,906
| -93% | -$18.6M | 0.01% | 576 |
|
|
2024
Q1 | $17.7M | Buy |
+860,948
| New | +$17.7M | 0.06% | 221 |
|